litlas
ログインアカウント作成

Linong Ji

2000–2026 年に発表

219
論文数
21,462
被引用数
72
h 指数
189
i10 指数

被引用数

Linong Ji の年別被引用数1987 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 7 件2003 年: 被引用 3 件2004 年: 被引用 2 件2005 年: 被引用 3 件2006 年: 被引用 2 件2007 年: 被引用 2 件2008 年: 被引用 1 件2010 年: 被引用 19 件2011 年: 被引用 53 件2012 年: 被引用 49 件2013 年: 被引用 84 件2014 年: 被引用 94 件2015 年: 被引用 100 件2016 年: 被引用 140 件2017 年: 被引用 132 件2018 年: 被引用 175 件2019 年: 被引用 618 件2020 年: 被引用 985 件2021 年: 被引用 961 件2022 年: 被引用 833 件2023 年: 被引用 618 件2024 年: 被引用 1,208 件2025 年: 被引用 750 件2026 年: 被引用 44 件1988〜2000 年は被引用が無いため表示していません2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,370 件、この内訳の 21.2%アメリカ合衆国: 引用元論文 1,729 件、この内訳の 15.4%イギリス: 引用元論文 743 件、この内訳の 6.6%イタリア: 引用元論文 442 件、この内訳の 4%オーストラリア: 引用元論文 403 件、この内訳の 3.6%ドイツ: 引用元論文 338 件、この内訳の 3%インド: 引用元論文 323 件、この内訳の 2.9%カナダ: 引用元論文 283 件、この内訳の 2.5%スペイン: 引用元論文 247 件、この内訳の 2.2%デンマーク: 引用元論文 227 件、この内訳の 2%フランス: 引用元論文 206 件、この内訳の 1.9%日本: 引用元論文 201 件、この内訳の 1.8%
0%21.2%その他 32.9%

機関

分野

  • Medicine71.6%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Health Professions2%
  • Neuroscience1.2%
  • Nursing1%
  • Psychology0.7%
  • その他4%

トピック

  • Diabetes Treatment and Management7.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.5%
  • Diabetes Management and Research4.9%
  • Gut microbiota and health3.7%
  • Diabetes and associated disorders3.5%
  • Pancreatic function and diabetes3.3%
  • その他71.3%

共著者

全論文

検索で開く
  1. Diagnosis and Management of Prediabetes

    著者: Justin B. Echouffo‐Tcheugui, Leigh Perreault, Linong Ji, Sam Dagogo‐Jack - JAMA 2023 被引用: 435

  2. Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance

    著者: Xiuying Zhang, Dongqian Shen, Zhiwei Fang, Zhuye Jie, Xinmin Qiu, Chunfang Zhang, Yingli Chen, Linong Ji - PLoS ONE 2013 被引用: 966

  3. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

    著者: David C. Klonoff, Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann, David Kerr, David Ahn, Anne L. Peters, Guillermo E. Umpierrez, Jane Jeffrie Seley, Nicole Y. Xu, Kevin T. Nguyen, Gregg D. Simonson, Michael S. D. Agus, Mohammed E. Al‐Sofiani, Gustavo Armaiz-Peña, Timothy S. Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas, Pierre‐Yves Benhamou, B. Wayne Bequette, Thomas Blevins, Marc D. Breton, Jessica R. Castle, J. Geoffrey Chase, Kong Y. Chen, Pratik Choudhary, Mark A. Clements, Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev - Journal of Diabetes Science and Technology 2022 被引用: 276

  4. Standards of medical care for type 2 diabetes in China 2019

    著者: Weiping Jia, Jianping Weng, Dalong Zhu, Linong Ji, Juming Lu, Zhiguang Zhou, Dajin Zou, Lixin Guo, Qiuhe Ji, Li Chen, Liming Chen, Jingtao Dou, Xiaohui Guo, Hongyu Kuang, Ling Li, Qifu Li, Xiaoying Li, Jing Liu, Xingwu Ran, Lixin Shi, Guangyao Song, Xinhua Xiao, Liyong Yang, Zhigang Zhao, On behalf of Chinese Diabetes Society - Diabetes/Metabolism Research and Reviews 2019 被引用: 763

  5. Sex- and age-related trajectories of the adult human gut microbiota shared across populations of different ethnicities

    著者: Xiuying Zhang, Huanzi Zhong, Yufeng Li, Zhun Shi, Huahui Ren, Zhe Zhang, Xianghai Zhou, Shanmei Tang, Xueyao Han, Yuxiang Lin, Fangming Yang, Dan Wang, Chao Fang, Zuodi Fu, Lianying Wang, Shida Zhu, Yong Hou, Xun Xu, Huanming Yang, Jian Wang, Karsten Kristiansen, Junhua Li, Linong Ji - Nature Aging 2021 被引用: 245

  6. Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

    著者: Johannes F.E. Mann, Peter Rossing, George L. Bakris, Nicolas Belmar, Heidrun Bosch‐Traberg, Robert S. Busch, David M. Charytan, Samy Hadjadj, Pieter Gillard, José Luis Górriz, Thomas Idorn, Linong Ji, Kenneth W. Mahaffey, Vlado Perkovic, Søren Rasmussen, Roland E. Schmieder, Richard E. Pratley, Katherine R. Tuttle - Nature Medicine 2024 被引用: 154

  7. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses

    著者: Natalie Nanayakkara, Andrea J. Curtis, Stéphane Héritier, Adelle M. Gadowski, Meda E. Pavkov, Timothy Kenealy, David R. Owens, Rebecca Thomas, Soon H Song, Jencia Wong, Juliana C.N. Chan, Andrea O. Y. Luk, Giuseppe Penno, Linong Ji, Viswanathan Mohan, Anandakumar Amutha, Pedro Romero‐Aroca, Danijela Gašević, Dianna J. Magliano, Helena Teede, John Chalmers, Sophia Zoungas - Diabetologia 2020 被引用: 374

  8. A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

    著者: Linong Ji, Hongwei� Jiang, Zhifeng Cheng, Wei Qiu, Lin Liao, Yawei Zhang, Xiaoli Li, Shuguang Pang, Lihui Zhang, Liming Chen, Tao Yang, Li Yan, Shen Qu, Jie Wen, Jieyu Gu, Huan Deng, Yanqi Wang, Li Li, Han Han‐Zhang, Qingyang Ma, Lei Qian - Nature Communications 2023 被引用: 95

  9. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations

    著者: Xiantong Zou, Xianghai Zhou, Zhanxing Zhu, Linong Ji - The Lancet Diabetes & Endocrinology 2018 被引用: 266

  10. Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial

    著者: Leili Gao, Byung‐Wan Lee, Manoj Chawla, Joshua Kim, Li Huo, Liying Du, Yan Huang, Linong Ji - Nature Medicine 2023 被引用: 95

  11. Prevalence of Diabetes among Men and Women in China

    著者: Wenying Yang, Juming Lu, Jianping Weng, Weiping Jia, Linong Ji, Jianzhong Xiao, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji, Dalong Zhu, Jiapu Ge, Lixiang Lin, Li Chen, Xiaohui Guo, Zhigang Zhao, Qiang Li, Zhiguang Zhou, Guangliang Shan, Jiang He - New England Journal of Medicine 2010 被引用: 3,055

  12. Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

    著者: Bo Zhang, Zhifeng Cheng, Ji Chen, Xin Zhang, Dexue Liu, Hongwei� Jiang, Guoqing Ma, Xiaoyun Wang, Shenglian Gan, Juan Sun, Ping Jin, Jianjun Yi, Bimin Shi, Jianhua Ma, Shandong Ye, Guixia Wang, Linong Ji, Xuejiang Gu, Ting Yu, Pei An, Huan Deng, Haoyu Li, Li Li, Qingyang Ma, Lei Qian, Wenying Yang - Diabetes Care 2023 被引用: 72

  13. Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis

    著者: Feng Sun, Shanshan Wu, Shuxia Guo, Kai Yu, Zhirong Yang, Lishi Li, Yuan Zhang, Xiaochi Quan, Linong Ji, Siyan Zhan - Diabetes Research and Clinical Practice 2015 被引用: 301

  14. New insights into the treatment of obesity

    著者: Matthias Blüher, Mohini Aras, Louis J. Aronne, Rachel L. Batterham, Francesco Giorgino, Linong Ji, Kirsi H. Pietiläinen, Oliver Schnell, Elena Tonchevska, John Wilding - Diabetes Obesity and Metabolism 2023 被引用: 143

  15. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    著者: Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, K. G. M. M. Alberti, Paul Zimmet, Stefano Del Prato, Linong Ji, S.M. Sadikot, William H. Herman, Stephanie A. Amiel, Lee M. Kaplan, Gaspar Taroncher‐Oldenburg, David E. Cummings, Delegates of the 2nd Diabetes Surgery Summit, Nizar Albache, Rachel L. Batterham, Deepak L. Bhatt, Camilo Boza, William T. Cefalu, Ricardo V. Cohen, Anita P. Courcoulas, Seán F. Dinneen, John B. Dixon, Ele Ferrannini, Paola Fioretto, Gema Frühbeck, Michel Gagner, Richard W. Grant, Sayeed Ikramuddin, Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe - Diabetes Care 2016 被引用: 971

  16. Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial

    著者: Linong Ji, Leili Gao, Hongwei� Jiang, Jing Yang, Lei Yu, Jie Wen, Chenghang Cai, Huan Deng, Liqi Feng, Baili Song, Qingyang Ma, Lei Qian - EClinicalMedicine 2022 被引用: 72

  17. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial

    著者: Lihui Zhang, Yunliang Zhang, Sheng'ai Shen, Xueying Wang, Luling Dong, Qiuyun Li, Weidong Ren, Yufeng Li, Jianling Bai, Qiuhong Gong, Hongyu Kuang, Lin Qi, Qiang Lü, Wenli Cheng, Yanjie Liu, Shuang Yan, Dong‐Hong Wu, Hui Fang, Fang Hou, Yingju Wang, Zhixia Yang, Lian Xu, Jianling Du, Ningling Sun, Ningling Sun, Guangwei Li, Linong Ji, Guangwei Li, Sheng'ai Shen, Lihui Zhang, Luling Dong, Qiuyun Li, Weidong Ren, Yufeng Li, Qiuyun Li, Weidong Ren, Lin Qi, Qiang Lü, Wenli Cheng, Yanjie Liu, Shuang Yan, Dong‐Hong Wu, Yanjie Liu, Ningling Sun, Donghong Wu, Guangwei Li, Fang Hou, Ningling Sun, Zhixia Yang, Lian Xu, Jianling Du, Ping Tu, Su Wang, Xinhua Yin, Wen-Jia Chen, Qing He, Zhongyan Shan, Xueqin Wang, Jin-Rong Liang, Chang Liu, Yun Xie, Binhong Duan, Zhongyan Shan, Zhengnan Gao, Li Li, Lijuan Jiang, Huimin Han, Binhong Duan, Li Sun, Bo Feng, Lingling Cao, Xinfang Wang, Huimin Han, Tong Zhang, Xiaoyan Liu, Qiuhong Gong, Lingling Cao, Xinfang Wang, Xiaoping Chen, Tong Zhang, Xiaoyan Liu, Qiuhong Gong - The Lancet Diabetes & Endocrinology 2023 被引用: 83

  18. Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

    著者: Feng Sun, Sanbao Chai, Kai Yu, Xiaochi Quan, Zhirong Yang, Shanshan Wu, Yuan Zhang, Linong Ji, Jun Wang, Luwen Shi - Diabetes Technology & Therapeutics 2014 被引用: 151

  19. Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China : A 30‐week, double‐blind, phase 3a, randomized trial

    著者: Linong Ji, Xiaolin Dong, Yiming Li, Yufeng Li, Soo Lim, Ming Liu, Ning Zu, Søren Rasmussen, Trine Vang Skjøth, Guoyue Yuan, Freddy G. Eliaschewitz - Diabetes Obesity and Metabolism 2020 被引用: 103

  20. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy

    著者: Brian C. Callaghan, Leili Gao, Yufeng Li, Xianghai Zhou, Evan L. Reynolds, Mousumi Banerjee, Rodica Pop‐Busui, Eva L. Feldman, Linong Ji - Annals of Clinical and Translational Neurology 2018 被引用: 196

  21. New-Onset Diabetes in Covid-19

    著者: Francesco Rubino, Stephanie A. Amiel, Paul Zimmet, George Alberti, Stefan R. Bornstein, Robert H. Eckel, Geltrude Mingrone, Bernhard O. Boehm, Mark E. Cooper, Zhonglin Chai, Stefano Del Prato, Linong Ji, David Hopkins, William H. Herman, Kamlesh Khunti, Jean Claude Mbanya, Éric Renard - New England Journal of Medicine 2020 被引用: 828

  22. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

    著者: Roseanne O. Yeung, Yuying Zhang, Andrea O. Y. Luk, Wenying Yang, Leorino Sobrepeña, Kun‐Ho Yoon, S. R. Aravind, Wayne Huey‐Herng Sheu, Thy Khue Nguyen, Risa Ozaki, Chaicharn Deerochanawong, Chiu Chi Tsang, Wing-Bun Chan, Eun Gyoung Hong, Trung Quan, Yu Cheung, Nicola Brown, Su Yen Goh, Ronald C.W., M. Mukhopadhyay, Arvind Kumar Ojha, Shaibal Chakraborty, Alice P.S. Kong, Winnie Lau, Weiping Jia, Wenhui Li, Xiaohui Guo, Rongwen Bian, Jianping Weng, Linong Ji, Mercedes Reyes-dela Rosa, Ronaldo M Toledo, Thep Himathongkam, Soon-Jib Yoo, C. C. Chow, Larry L-T. Ho, Lee‐Ming Chuang, Greg Tutino, Peter C.Y. Tong, Wing‐Yee So, Troels Wolthers, Gary T.C. Ko, Greg Lyubomirsky, Juliana C.N. Chan - The Lancet Diabetes & Endocrinology 2014 被引用: 302

  23. Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial

    著者: Xiuying Zhang, Zhiwei Fang, Chunfang Zhang, Huihua Xia, Zhuye Jie, Xueyao Han, Yingli Chen, Linong Ji - Diabetes Therapy 2017 被引用: 183

  24. NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III

    著者: Qi Huang, Xiantong Zou, Xin Wen, Xianghai Zhou, Linong Ji - Frontiers in Medicine 2021 被引用: 113